CorMedix Inc (NASDAQ:CRMD) has a beta value of 1.63 and has seen 0.42 million shares traded in the recent trading session. The company, currently valued at $846.91M, closed the recent trade at $12.49 per share which meant it gained $0.35 on the day or 2.86% during that session. The CRMD stock price is -10.89% off its 52-week high price of $13.85 and 71.1% above the 52-week low of $3.61. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.16 million shares traded. The 3-month trading volume is 1.86 million shares.
The consensus among analysts is that CorMedix Inc (CRMD) is Buy stock at the moment, with a recommendation rating of 1.00. 1 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight.
CorMedix Inc (NASDAQ:CRMD) trade information
Over the past 30 days, the shares of CorMedix Inc (NASDAQ:CRMD) have changed 29.40%. Short interest in the company has seen 8.45 million shares shorted with days to cover at 3.87.
Wall Street analysts have a consensus price target for the stock at $9, which means that the shares’ value could drop -38.78% from the levels at last check today.. The projected low price target is $9.0 while the price target rests at a high of $9.0. In that case, then, we find that the latest price level in today’s session is 27.94% off the targeted high while a plunge would see the stock lose 27.94% from the levels at last check today..
CorMedix Inc (CRMD) estimates and forecasts
The company’s shares have gained 27.68% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 29.80% over the past 5 years.
CRMD Dividends
CorMedix Inc is expected to release its next earnings report on 2025-May-05 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
CorMedix Inc (NASDAQ:CRMD)’s Major holders
Insiders own 1.19% of the company shares, while shares held by institutions stand at 36.98% with a share float percentage of 37.43%. Investors are also buoyed by the number of investors in a company, with CorMedix Inc having a total of 186.0 institutions that hold shares in the company. The top two institutional holders are BLACKROCK INC. with over 3.55 million shares worth more than $15.39 million. As of 2024-06-30, BLACKROCK INC. held 6.167% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 2.9 million shares as of 2024-06-30. The firm’s total holdings are worth over $12.57 million and represent 5.0373% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . As of Mar 31, 2025 , the former fund manager holds about 2.92% shares in the company for having 1.98 shares of worth $25.03 million while later fund manager owns 1.62 shares of worth $20.48 million as of Mar 31, 2025 , which makes it owner of about 2.39% of company’s outstanding stock.
